US$ 24.09
semaglutide like medications A Guide to GLP-1s: Resources and support for GLP-1 GLP-1s | AgelessRx
Description
Wegovy is indicated for people with a body mass index of at least 30 considered to have obesity or those with a BMI of at least 27 considered overweight and at least one weight-related health condition like high blood pressure or cholesterol

Medhati P, Saleh OS, Nimeri A et al (2024) Outcomes and management of re-establishing bariatric patients

She said playing a role in supporting weight loss journeys for such a long time is a "huge differentiation and a really strong foundation to build upon." Having a more long-term view of the weight management space also plays into how the company is thinking about the role of GLP-1s in the broader patient journey, she said
To build on this progress, larger randomized controlled trials are necessary to validate these findings. This is the first study of its kind to explore the use of semaglutide for HS

[DOI] [PubMed] [Google Scholar] 232

But it works and it is the right tool for you are two very different questions